People

Torsten Hombeck

Torsten Hombeck has served as Scipher Medicine’s interim chief financial officer since March 2026. His biotechnology finance career includes CFO roles at Akari Therapeutics, Aspira Women’s Health, Agennix and GPC Biotech, and executive positions at Promethera Biosciences and Cytonet. He holds an MBA and a doctorate in finance from EBS University of Business and Law in Germany.